Amedeo Smart

Free Medical Literature Service

 

Amedeo

Inflammatory Bowel Diseases
  Free Subscription

Articles published in
Proc Natl Acad Sci U S A
    September 2025
  1. CHEN X, Hwang HS, Li B, Zhao Y, et al
    Nuclear receptor coregulator NRIP1 R448G modulates T cell gut homing to control intestinal inflammation.
    Proc Natl Acad Sci U S A. 2025;122:e2508269122.
    >> Share

    August 2025
  2. PARK JD, Lee SR, Dhennezel C, Taylor N, et al
    Elucidating the role of Campylobacter concisus-derived indole metabolites in gut inflammation and immune modulation.
    Proc Natl Acad Sci U S A. 2025;122:e2514071122.
    >> Share

    July 2025
  3. TIAN M, Hao F, Wang X, Zheng X, et al
    OGG1 augments the transcriptional activation of Foxp3 to promote iTreg differentiation for IBD alleviation.
    Proc Natl Acad Sci U S A. 2025;122:e2424733122.
    >> Share

  4. CRAWFORD CJ, Tomlinson CWE, Gunawan C, Chen Z, et al
    Arylsulfamates inhibit colonic Bacteroidota growth through a sulfatase-independent mechanism.
    Proc Natl Acad Sci U S A. 2025;122:e2414331122.
    >> Share

    June 2025
  5. OTA N, Davies CW, Kang J, Yan D, et al
    Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling.
    Proc Natl Acad Sci U S A. 2025;122:e2501635122.
    >> Share

    May 2025
  6. SINGH AK, Ainciburu M, Wynne K, Bhat SA, et al
    De novo DUOX2 expression in neutrophil subsets shapes the pathogenesis of intestinal disease.
    Proc Natl Acad Sci U S A. 2025;122:e2421747122.
    >> Share

    December 2024
  7. YANG J, Tan S, Ge S, Yang M, et al
    Cyanobacteria-probiotics symbionts for modulation of intestinal inflammation and microbiome dysregulation in colitis.
    Proc Natl Acad Sci U S A. 2024;121:e2403417121.
    >> Share

    September 2024
  8. CAO W, Xiong Y, Chen D
    Contradiction: Inhibiting inflammation and immunosuppression in the treatment of IBD.
    Proc Natl Acad Sci U S A. 2024;121:e2415439121.
    >> Share

  9. HUANG B, Yin T, Fu S, Liu L, et al
    Inflammation-oriented montmorillonite adjuvant enhanced oral delivery of anti-TNF-alpha nanobody against inflammatory bowel disease.
    Proc Natl Acad Sci U S A. 2024;121:e2320482121.
    >> Share

    July 2024
  10. CHENG C, Xing Z, Zhang W, Zheng L, et al
    Iron regulatory protein 2 contributes to antimicrobial immunity by preserving lysosomal function in macrophages.
    Proc Natl Acad Sci U S A. 2024;121:e2321929121.
    >> Share

  11. XIONG M, Liu Z, Wang B, Sokolich T, et al
    The epithelial C15ORF48/miR-147-NDUFA4 axis is an essential regulator of gut inflammation, energy metabolism, and the microbiome.
    Proc Natl Acad Sci U S A. 2024;121:e2315944121.
    >> Share

    April 2024
  12. HOU D, Yu T, Lu X, Hong JY, et al
    Sirt2 inhibition improves gut epithelial barrier integrity and protects mice from colitis.
    Proc Natl Acad Sci U S A. 2024;121:e2319833121.
    >> Share

    January 2024
  13. YANG X, Li G, Lou P, Zhang M, et al
    Excessive nucleic acid R-loops induce mitochondria-dependent epithelial cell necroptosis and drive spontaneous intestinal inflammation.
    Proc Natl Acad Sci U S A. 2024;121:e2307395120.
    >> Share

    August 2023
  14. MENG F, Jiang X, Wang X, Zheng Q, et al
    Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis.
    Proc Natl Acad Sci U S A. 2023;120:e2120771120.
    >> Share

  15. XIA JY, Hepler C, Tran P, Waldeck NJ, et al
    Engineered calprotectin-sensing probiotics for IBD surveillance in humans.
    Proc Natl Acad Sci U S A. 2023;120:e2221121120.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016